Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis [Phase 2]
KZR-616, an immunoproteasome inhibitor, was studied in a Phase 2 trial for active polymyositis and dermatomyositis by Kezar Life Sciences; t…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: A Study In Adults With Moderate To Severe Dermatomyositis [Phase 2]
Phase 2 clinical trial in adults with moderate to severe dermatomyositis completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of Froniglutide (PF1801) in patients with idiopathic inflammatory myopathies, in…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis [Phase 2]
Phase 2 trial evaluating apremilast for safety and efficacy in adult dermatomyositis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis [Phase 2]
Phase 2 trial of JBT-101 in dermatomyositis was terminated; results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Interleukin-2 on Active Dermatomyositis [Phase 3]
Phase 3 clinical trial update evaluating interleukin-2 for active dermatomyositis.
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Abatacept in Juvenile Dermatomyositis [Phase 4]
Phase 4 clinical trial evaluating abatacept in juvenile dermatomyositis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis [Phase 3]
Phase 3 trial assessing the efficacy and safety of lenabasum in dermatomyositis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis [Phase 4]
A Phase 4 trial evaluating efficacy and safety of triple therapy in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disea…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]
Phase 3 trial evaluating abatacept with standard therapy versus standard therapy alone in adults with active inflammatory myopathy (polymyos…
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients [Phase 4]
Phase 4 trial update evaluating a JAK inhibitor for adult Dermatomyositis with anti-MDA5 antibodies, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis [Phase 3]
Phase 3 trial evaluating Octanorm for dermatomyositis has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of Octagam 10% in patients with dermatomyositis has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Abatacept Treatment in Polymyositis and Dermatomyositis [Phase 2]
Phase 2 trial update evaluating abatacept for polymyositis and dermatomyositis has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis [Phase 2]
Phase 2 clinical trial update for tocilizumab in refractory polymyositis and dermatomyositis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus [Phase 2, Phase 3]
Phase 2/3 trial investigating prednisolone with tacrolimus for myositis-associated pneumonitis has completed; results reported.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis [Phase 2]
Phase 2 trial evaluating infliximab (Remicade) for treatment of dermatomyositis and polymyositis has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Trial of IMO-8400 in Adult Patients With Dermatomyositis [Phase 2]
Phase 2 trial results for IMO-8400 in adult Dermatomyositis have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis [Phase 2]
Phase 2 trial of BAF312 (likely on symptomatic improvement in polymyositis and dermatomyositis) was terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Safety and Efficacy of BAF312 in Dermatomyositis [Phase 2]
Phase 2 trial of BAF312 in active dermatomyositis was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study [EARLY_Phase 1]
An early-phase proof-of-concept trial of Hizentra (subcutaneous immunoglobulin) in dermatomyositis was terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis [NA]
A clinical trial update evaluating high-intensity interval training as an intervention for recent-onset polymyositis and dermatomyositis. Th…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis [Phase 2]
Phase 2 trial evaluating topical sodium thiosulfate in combination with a fractional carbon dioxide laser for dermatomyositis-associated cal…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Acthar in Treatment of Refractory Dermatomyositis and Polymyositis [Phase 2]
Phase 2 trial of Acthar Gel for refractory dermatomyositis and polymyositis has completed, and the results were posted in August 2017.
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Basiliximab Treating Interstitial Pneumonia of CADM [Phase 2]
Phase 2 trial investigating basiliximab for interstitial pneumonia in clinically amyopathic dermatomyositis (CADM).